Business · 05/10/2009
FDA Releases Draft Guidance on H. pylori-Associated Duodenal Ulcer Disease Treatment
The FDA has made available a draft guidance document to help pharmaceutical companies develop effective treatments for adults with duodenal ulcers caused by H. pylori bacteria, with the goal of reducing ulcer recurrence.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →